Phase 2 study design based on successful Phase 1/2 trial including use of Tinnitus Functional Index (TFI) responder analysis for primary efficacy endpoint Patient enrollment criteria refined to enrich study population Top-line results expected in mid-2022 SAN DIEGO , March 25, 2021 (GLOBE NEWSWIRE)

Apply Now